As of 12:16pm ET
| +0.03 / +1.24%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a +1,334.43% increase from the last price of 2.44.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.